The MarketWatch News Department was not involved in the creation of this content. -- Non-human primate study results demonstrate improvements in skeletal and cardiac muscle delivery efficacy, safety ...
Dyno Therapeutics CEO and co-founder Eric Kelsic, PhD, likens his company’s development of transformative AI-designed adeno-associated virus (AAV) vectors for gene therapy to climbing a mountain—a ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, today announced that Roche (SIX: RO, ...
WATERTOWN, Mass., November 11, 2025--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback